tiprankstipranks
Arcutis Biotherapeutics Inc (ARQT)
:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Income Statement

Compare
791 Followers

Arcutis Biotherapeutics Income Statement

Last quarter (Q4 2024), Arcutis Biotherapeutics's total revenue was $71.36M, an increase of 427.58% from the same quarter last year. In Q4, Arcutis Biotherapeutics's net income was $-10.79M. See Arcutis Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 196.54M$ 59.61M$ 3.69M$ 0.00$ 0.00
Gross Profit
$ 177.41M$ 54.62M$ 2.93M$ -763.00K$ -455.00K
Operating Expenses
$ 305.81M$ 295.72M$ 304.56M$ 206.53M$ 136.65M
Depreciation and Amortization
$ 2.60M$ 1.88M$ 1.25M$ 763.00K$ 455.00K
EBITDA
$ -109.63M$ -227.43M$ -294.55M$ -205.59M$ -135.22M
Operating Income
$ -128.40M$ -241.10M$ -301.63M$ -206.53M$ -136.65M
Other Income/Expenses
$ -10.99M$ -17.93M$ -9.83M$ 173.00K$ 967.00K
Pretax Income
$ -139.39M$ -259.03M$ -311.46M$ -206.36M$ -135.68M
Net Income
$ -140.04M$ -262.14M$ -321.29M$ -205.90M$ -135.68M
Per Share Metrics
Basic EPS
$ -1.16$ -3.78$ -5.84$ -4.17$ -3.80
Diluted EPS
$ -1.16$ -3.78$ -5.84$ -4.17$ -3.80
Weighted Average Shares Outstanding
120.96M 69.31M 55.03M 49.41M 35.67M
Weighted Average Shares Outstanding (Diluted)
120.96M 69.31M 55.03M 49.41M 35.67M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis